Editorial on "Can CT-PET and endoscopic assessment post-neoadjuvant chemoradiotherapy predict residual disease in esophageal cancer".
Editorial on "Can CT-PET and endoscopic assessment post-neoadjuvant chemoradiotherapy predict residual disease in esophageal cancer".
复制标题
DOI：
10.21037/jtd.2017.09.117
复制
发表时间：
2017-12
影响因子：
2.5
通讯作者：
Chia-Ju Liu;W. Lu
中科院分区：
文献类型：
--
作者：
Chia-Ju Liu;W. Lu
新辅助放化疗(NCRT)再手术是目前可切除食道癌最常用的治疗方式(1)。食道切除和胃肠道连续性重建是广泛和具有挑战性的程序(2)。
Neoadjuvant chemoradiation (nCRT) followed by surgery is the most common treatment modality for resectable esophageal cancer nowadays (1). Esophagectomy and gastrointestinal continuity reconstruction are extensive and challenging procedures (2).